Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemia

Leukemia. 2020 Dec;34(12):3388-3392. doi: 10.1038/s41375-020-0973-z. Epub 2020 Jul 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / therapeutic use*
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • guadecitabine
  • Azacitidine